INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

IMNMImmunome Inc.

CIK 0001472012

EDGAR filingsOpen in network
Disclosed transactions41
Buys / sells1 / 19
Max Insider Score40
Connections7with evidence

IMNM · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
18.0K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Lechleider RobertChief Medical Officer · Jun 29, 2026
  • ← Insider ofevidence
    Boylan James PDirector · Jun 12, 2026
  • ← Insider ofevidence
    Rosett MaxChief Financial Officer · Apr 3, 2026
3
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M
$24K
18.0K sh
Sep 11, 2026
Sep 15, 2026
traded Sep 11, 2026
+4d
SEC FORM 4

Evidence

11
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$334K
13.2K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC FORM 4

Evidence

2
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift · 10b5-1 plan
G—
8,800 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC FORM 4

Evidence

19
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$1.63M
62.3K sh
Aug 11, 2026Aug 12, 2026
traded Aug 11, 2026
+1dSEC FORM 4

Evidence

8
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$264K
10.1K sh
Aug 10, 2026Aug 12, 2026
traded Aug 10, 2026
+2dSEC FORM 4

Evidence

8
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$301K
11.0K sh
Aug 12, 2026Aug 12, 2026
traded Aug 12, 2026
+0dSEC FORM 4

Evidence

11
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$543K
20.8K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC FORM 4

Evidence

11
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$397K
15.2K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC FORM 4

Evidence

26
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$499K
22.7K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

30
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$377K
16.1K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

16
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$409K
16.9K sh
Jul 7, 2026Jul 7, 2026
traded Jul 7, 2026
+0dSEC FORM 4

Evidence

23
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$2.00M
83.1K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

19
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$480K
55.0K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

9
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
55.0K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

26
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$369K
16.2K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

33
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$794K
40.6K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

3
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
55.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

29
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$298K
14.4K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

17
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$480K
55.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

10
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$63K
60.0K sh
Jun 15, 2026Jun 17, 2026
traded Jun 15, 2026
+2dSEC FORM 4

Evidence

0
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
60.0K sh
Jun 15, 2026Jun 17, 2026
traded Jun 15, 2026
+2dSEC FORM 4

Evidence

27
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
60.0K sh
Jun 15, 2026Jun 17, 2026
traded Jun 15, 2026
+2dSEC FORM 4

Evidence

9
BP
Boylan James PDirector
IMNMImmunome Inc.
Grant or award
A—
9,897 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC FORM 4

Evidence

31
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$1.39M
63.7K sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC FORM 4

Evidence

11
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$33K
31.8K sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC FORM 4

Evidence

14
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$54K
39.7K sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC FORM 4

Evidence

10
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$30K
1,344 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC FORM 4

Evidence

11
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
31.8K sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC FORM 4

Evidence

0
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
39.7K sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC FORM 4

Evidence

21
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$204K
9,438 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC FORM 4

Evidence

20
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift
G—
6,291 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC FORM 4

Evidence

11
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$251K
11.3K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

18
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$8.08M
371.9K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

12
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift
G—
1,000 sh
Dec 19, 2025Dec 22, 2025
traded Dec 19, 2025
+3dSEC FORM 4

Evidence

40
TP
Tsai PhilipChief Technical Officer
IMNMImmunome Inc.
Open-market purchase
BUY$205K
10.0K sh
Dec 19, 2025Dec 22, 2025
traded Dec 19, 2025
+3dSEC FORM 4

Evidence

12
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift
G—
1,000 sh
Dec 19, 2025Dec 22, 2025
traded Dec 19, 2025
+3dSEC FORM 4

Evidence

12
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift
G—
1,000 sh
Dec 19, 2025Dec 22, 2025
traded Dec 19, 2025
+3dSEC FORM 4

Evidence

12
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift
G—
1,000 sh
Dec 19, 2025Dec 22, 2025
traded Dec 19, 2025
+3dSEC FORM 4

Evidence

12
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift
G—
1,000 sh
Dec 19, 2025Dec 22, 2025
traded Dec 19, 2025
+3dSEC FORM 4

Evidence

12
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift
G—
1,000 sh
Dec 19, 2025Dec 22, 2025
traded Dec 19, 2025
+3dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Barchas IsaacDirector · Dec 23, 2025
  • ← Insider ofevidence
    Higgins JackChief Scientific Officer · Dec 22, 2025
  • ← Insider ofevidence
    Tsai PhilipChief Technical Officer · Dec 22, 2025